A Comparative QSAR Analysis of Quinazoline Analogues as Tyrosine Kinase (erbB-2) Inhibitors

By  

Medicinal Chemistry, Vol. 7, Iss. 3, 2011-05 ,pp. : 200-212

Bentham Science Publishers

Access to resources Recommend Favorite

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 775-793

Bentham Science Publishers

Access to resources Recommend Favorite

Lessons from the Drug Discovery of Lapatinib, a Dual ErbB1/2 Tyrosine Kinase Inhibitor

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-03 ,pp. : 435-460

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular Effects of Neuregulin-1/ErbB Signaling: Role in Vascular Signaling and Angiogenesis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4899-4905

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of 1B -adrenoceptor expression by agonist and protein kinase inhibitors

By Bird K.S.   Anderson J.L.   Toews M.L.  

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 267-275

Elsevier

Access to resources Recommend Favorite